“…Similar to the study by Kessing et al (2008), the researchers conducted a Poisson regression analysis, comprising dementia diagnosis as the outcome and the number of prescriptions for lithium, anticonvulsants, antidepressants, and antipsychotics as the variables of interest, with censoring during schizophrenia diagnosis, death, or at the end of the study period (31 December 2005). Continued prescriptions of lithium were associated with a decreased rate of dementia ([number of prescriptions]: [2][3][4], RR = 0.46, 95% CI 0.21-1.01; [5][6][7][8][9], RR = 0.38, 95% CI 0.16-0.86; [10][11][12][13][14][15][16][17][18][19], RR = 0.39 95% CI 0.19-0.81; [20~], and RR = 0.44 95% CI 0.23-0.85). Nonetheless, continued prescriptions of anticonvulsants, antidepressants, or antipsychotics were not significantly associated with a decreased rate of dementia.…”